European Union Trademark file information

016502395

Navigo


March 23, 2017

Trademark Summary

The trademark application Navigo was filed by Navigo Proteins GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on May 4, 2017, and it was registered by office on August 13, 2017 without any oppositions.

It was designated 'Basic Application' for International Application 1372947 at the World Intellectual Property Organization (WIPO).

The application was filed in German (English was selected as the second language).

Cancellation Proceedings

A total of undefined cancellation proceedings were initiated against the trademark registration in 2017.The first Cancellation was filed by Navignostics AG (represented by SCHULZ JUNGHANS PATENTANWÄLTE PARTGMBB) on December 21, 2023 and Adversarial proceedings are ongoing.

International trade mark of the trademark registration was recorded on November 2, 2017. Change of name and professional address of the trademark registration was recorded on January 11, 2021. Application for revocation or for a declaration of invalidity of the trademark registration was recorded on December 24, 2023.


Goods And Services

  • The mark was filed in class 1 with Chemicals, biological, analytical, and/or chromatographic preparations, active agents, and/or compositions, in particular containing proteins, polypeptides, peptides, for industrial and scientific applications, including laboratory analysis, other than for medical and veterinary use.
  • The mark was filed in class 5 with Diagnostic, therapeutic, analytical, biological, chemical, biochemical substances, active agents, and/or compositions for medical, veterinary, and/or diagnostic use.
  • The mark was filed in class 42 with following description of goods:
    1. Scientific, technological and industrial services and research, in particular in the pharmaceutical, diagnostic, analytical or biochemical field
    2. Services and research for identification, further development and use of biochemical, pharmaceutical, analytical or diagnostic products
    3. Molecular biological, biotechnological, biochemical or pharmaceutical laboratory services
    4. Research and development in the field of medical and veterinary diagnostics and treatment using molecular biological, genetic engineering, biotechnological or biochemical methods, and in the field of identification, screening and development of pharmaceutically active components, and test methods and test kits.